Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Upadacitinib may cause hair loss.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

The finasteride patch effectively treats hair loss by enhancing skin absorption.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

EFFC might be common but underreported.